SEPT9: From pan-cancer to lung squamous cell carcinoma
This is the first study to systematically analyze the role of SEPT9 in cancers and innovatively apply the mitotic spindle-associated model to LUSC, fully demonstrating its potential as a valuable biomarker for cancer screening and prognosis, and highlighting its application value in promoting immunotherapy and chemotherapy, particularly for LUSC.
Authors
- Wenwen Wang (ORCID: https://orcid.org/0000-0002-1545-4369)
- Shirong Zhang (ORCID: https://orcid.org/0000-0001-9334-1637)
- Xiaochen Zhang (ORCID: https://orcid.org/0009-0003-7728-3184)
- Ping Gui
- Yuzhou Nie
- Qizhen Zou
- Shenglin Ma
Institutions
- Zhejiang Chinese Medical University (CN)
- Suzhou Institute of Biomedical Engineering and Technology (CN)
- Zhejiang Cancer Hospital (CN)
- Hangzhou Cancer Hospital (CN)
- First Affiliated Hospital Zhejiang University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1186/s12885-024-12877-4
- Citations
- 4
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Natural Science Foundation of Zhejiang Province